Cerebrospinal fluid immunity biomarkers in Alzheimer’s and Parkinson’s disease

Takeaway

  • Cerebrospinal fluid (CSF) immunity biomarker concentrations in Alzheimer’s disease (AD) and Parkinson’s disease (PD) correlate with molecular and cellular pathology rather than disease diagnosis.

Why this matters

    Reproducible biomarkers from this study, if further validated, may be helpful in interventional clinical trials as markers for neuroinflammation.